NDC 54575-374
CINNAMON
Cinnamon
CINNAMON is a Percutaneous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Allergy Laboratories, Inc.. The primary component is Cinnamon.
| Product ID | 54575-374_dbe7bebd-e445-4e59-8302-e706b795fbde |
| NDC | 54575-374 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CINNAMON |
| Generic Name | Cinnamon |
| Dosage Form | Injection, Solution |
| Route of Administration | PERCUTANEOUS; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | CINNAMON |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Dietary Proteins [CS],Food Additives [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
Packaging
NDC 54575-374-10
10 mL in 1 VIAL, MULTI-DOSE (54575-374-10)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 54575-374-10 [54575037410]
CINNAMON INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-374-30 [54575037430]
CINNAMON INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-374-02 [54575037402]
CINNAMON INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
NDC 54575-374-50 [54575037450]
CINNAMON INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2020-01-31 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| CINNAMON | 1 g/20mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Food Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Dietary Proteins [CS]
- Food Additives [CS]
- Allergens [CS]
NDC Crossover Matching brand name "CINNAMON" or generic name "Cinnamon"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0268-6123 | CINNAMON | CINNAMON |
| 22840-5717 | Cinnamon | Cinnamomum verum |
| 36987-1674 | Cinnamon | Cinnamon |
| 36987-1675 | Cinnamon | Cinnamon |
| 36987-1676 | Cinnamon | Cinnamon |
| 36987-1677 | Cinnamon | Cinnamon |
| 49288-0114 | Cinnamon | Cinnamon |
| 54575-374 | CINNAMON | cinnamon |
| 0220-1406 | Cinnamomum | CINNAMON |
| 68428-322 | Cinnamomum | CINNAMON |
| 71919-204 | Cinnamomum | CINNAMON |
Trademark Results [CINNAMON]
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.